Classic antiepileptic and new generation antiepileptic drugs: Gender differences in effectiveness and adverse drug reactions;Fármacos antiepilépticos clásicos y de nueva generación: Diferencias de sexo en la efectividad y en las reacciones adversas

Neurologia

Volumn 20, Issue 2, 2005, Pages 71-76

  Falip, M ^a,af   Artazcoz, L ^b   De La Pena P ^c   Perez Sempere A ^d   Martin Moro M ^e   Codina, M ^f   Padro L ^a   Forcadas, I ^g   Pondal, M ^h   Castro, D ^h   Morales, D ⁱ   Bertol, V ^j   Dominguez, M ^k   Arribas, A ^l   Baiges, J J ^m   Martin, G ^m   Cubero, A ⁿ   Galiano, M L ^o   Fossas, P ^p   Mauri, J ^q   Martinez Ferri M ^r   Oliveras Ley, C ^s   Leno, C ^t   Oterino, A ^t   Martinez, F ^u   Vadillo, F ^v   Ricoba, R ^w   De Toledo, M ^x   Burset, J ^y   Porta, J ^z   Sainz Diaz R ^z   Matinez Salio A ^z   Molins, A ^aa   Sancho Rieger, G ^ab   Escartin, A ^ac   Campos, D ^ad   Saiz Diaz, A ^ae   more..

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d HOSPITAL VEGA BAJA   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^g HOSPITAL DE CRUCES   (Spain)

^h HOSPITAL SEVERO OCHOA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^j HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^k HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^l Hospital Comarcal Alt Penedès   (Spain)

^m HVC Tortosa   (Spain)

ⁿ HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^o Ambulatorio A1 Moratalaz   (Spain)

^p Ambulatorio A1 Moratalaz ^*  (Spain)

^q HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^r HOSPITAL MÚTUA DE TERRASSA   (Spain)

^s HOSPITAL DEL MAR   (Spain)

^t HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^u HOSPITAL TXAGORRITXU   (Spain)

^v HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^w Hospital V Alvarez Buylla Mieres   (Spain)

^x HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^y Hospital San Dureta   (Spain)

^z Ambulatorio de Area 11   (Spain)

^aa HOSPITAL JOSEP TRUETA   (Spain)

^ab HGU Valencia   (Spain)

^ac HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^ad Hospital General de Zamora   (Spain)

^ae HOSPITAL NUESTRA SEÑORA DE SONSOLES   (Spain)

^af Hospital Nuestra Senora de Sonsoles ^*  (Spain)

more..

Author keywords

Adverse reactions; Antiepileptic drugs; Effectiveness; Quality of life; Sex related factors

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; GABAPENTIN; LAMOTRIGINE; NEW DRUG; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; ANTICONVULSANT THERAPY; ARTICLE; DRUG EFFICACY; DRUG SAFETY; EPILEPSY; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; QUALITY OF LIFE; QUESTIONNAIRE; SEIZURE; SEX DIFFERENCE; SHORT FORM 36; SIDE EFFECT;

EID: 20244382129     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Tran C, Knowten SR, Liu BA, Shear NH. Gender differences in adverse drug reactions. J Clin Pharmacol 1998;38:1003-9.
2. Rademaker M. Do women have more adverse drug reactions? Am J Clin Dermatol 2001;2:349-51.
3. Whitte WB, Johnson MF, Black HR, Elliott WJ, Sicca DA. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy. Am J Hypertens 2001;14:1239-47.
4. Kando JC, Yonkers KA, Cole JO. Gender as a risk factor for adverse events to medications. Drugs 1995;50:1-6.
5. Wong IC, Mawer GE, Sander JW. Factors influencing the indicence of lamotrigine-related skin rash. Ann Pharmacother 1999;33:1037-42.
6. Wild JM, Martínez C, Reinshagen G, Harding GF. Characteristics of a unique visual field defect attributed to vigabatrin. Epilepsia 1999;40:1784-94.
7. Harris RZ, Benet LZ, Schwartz JB. Gender effects in pharmacokinetics and pharmacodynamics. Drugs 1995;50:222-39.
8. Lew KH, Ludwig EA, Milad MA, Donovan K, Middleton E, Ferry JJ, et al. Gender-based effect on methylprednisolone pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 1993;54:402-14.
9. Ware JJ, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992;30:473-83.
10. Anderson RT, Aaronson NK, Wilkin D. Critical review of the international assessments of health-related quality of life. Quality Life Res 1993;2:369-95.
11. Alonso J, Regidor E, Barrio G, Prieto L, Rodriguez C, de la Fuente L. Population reference values of the Spanish versión of the Health Questionnaire SF-36. Med Clin (Barc) 1998;111:410-6.
12. Armitage P. Statistical methods in medical research. Oxford: Blackwell Scientific Publications, 1985.
13. Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, et al. A comparison of carbamacepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized epilepsy. N Engl J Med 1985;313:145-51.
14. Brodie MJ, Richens A, Yuen WC for UKC. Lamotrigine/Carbamacepine Monotherapy Trial Group. Double-blind comparison of lamotrigine and carbamacepine in newly diagnosed epilepsy. Lancet 1995;345:476-9.
15. Reunanen M, Dam M, Yuen WC. A randomised open multicenter comparative trial of lamotrigine and carbamacepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsy Res 1996;23:149-55.
16. Steiner TJ, Dellaportas CI, Findley U, Gross M, Gibberd FB, Perkin GD, et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double blind comparison with phenytoin. Epilepsia 1999;40:601-7.
17. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997;38:859-80.
18. Hohmann AA. Gender bias in psychotropic drug prescribing in primary care. Med Care 1988;27:478-90.
19. Falconer MA, Davidson S. Coarse features in epilepsy as a consequence of anticonvulsant therapy. Lancet 1973;2:1112-4.
20. Kim WJ, Park S, Lee S, Lee J, Kim JY, Lee BY. The prognosis for control of seizures in patients with MRI evidence for Mesial temporal lobe sclerosis. Epilepsia 1999;40:290-3.
21. Lindsay J, Qunsted C, Richard P. Long-term outcome in children with temporal lobe seizures, social outcome and childhood factors. Dev Med Child Neurol 1979;21:285-98.
22. Jacoby A, Baker G, Steen N, Potts P, Chadwick DW. The clinical course of epilepsy and its psychosocial correlates: finding from a UK community study. Epilepsia 1996;37:148-61.
23. Sander JW. The epidemiology of epilepsy revisited. Curr Opin Neurol 2003;16:165-70.